Vaseem Mahboob is CFO at ENDOLOGIX INC /DE/ (ELGX). They have made 4 open-market trades across 2 companies since 2016, most recently 2026-08-07.
CIK 0001655157
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
3 open-market purchases totalling $398K since 2016, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| KMTS | 60,609 | $1.6M |
| ELGX | 115,341 | $25K |
| INSY | 14,083 | $4K |
| Total | $1.7M |
Shares reported on the most recent Form 4, priced at the 2026-08-11 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| KMTS | SELL · 10b5-1 | 2026-08-07 | 2026-08-11 | $25.88 | $680K | -3.3% | -15.6% | — |
| KMTS | SELL · 10b5-1 | 2026-08-04 | 2026-08-06 | $24.68 | $173K | +8.0% | -0.9% | — |
| KMTS | SELL | 2026-07-30 | 2026-08-03 | $22.99 | $418K | +15.1% | +6.9% | — |
| ELGX | BUY | 2019-04-03 | 2019-04-03 | $6.61 | $200K | -15.0% | -9.1% | +5.5% |
| ELGX | BUY | 2018-08-16 | 2018-08-20 | $2.43 | $73K | -12.9% | -33.5% | -64.1% |
| ELGX | BUY | 2016-12-13 | 2016-12-15 | $6.25 | $125K | -23.1% | -8.4% | -6.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.